Why anomaly detection analytics matter for a hospital’s bottom line

The chief information officer of the 25-bed New Mexico nonprofit discusses plan for some new clinical automation tools. He also describes how he's using AI to help with network defense, and how that's enabling gains in other areas.

Mati Gill, AION Labs CEO, provides an update on the company’s nine AI-enabled drug discovery portfolio companies, how the organizations are making an impact in life sciences and what’s next for AION, including exploring quantum technologies.

Marten den Haring, CEO of Lirio, says the company uses its Large Behavior Model, which blends behavioral science with artificial intelligence, with the goal of driving consumer engagement in healthcare at the personal level.